164 related articles for article (PubMed ID: 30419774)
1. Associations between Community-Acquired Pneumonia and Proton Pump Inhibitors in the Laryngeal/Voice-Disordered Population.
Cohen SM; Lee HJ; Leiman DA; Roy N; Misono S
Otolaryngol Head Neck Surg; 2019 Mar; 160(3):519-525. PubMed ID: 30419774
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic management of voice disorders by general medicine providers and otolaryngologists.
Cohen SM; Lee HJ; Roy N; Misono S
Laryngoscope; 2018 Mar; 128(3):682-689. PubMed ID: 28944537
[TBL] [Abstract][Full Text] [Related]
3. Community acquired pneumonia incidence before and after proton pump inhibitor prescription: population based study.
Othman F; Crooks CJ; Card TR
BMJ; 2016 Nov; 355():i5813. PubMed ID: 28715344
[No Abstract] [Full Text] [Related]
4. Risk of community-acquired pneumonia in veteran patients to whom proton pump inhibitors were dispensed.
Hermos JA; Young MM; Fonda JR; Gagnon DR; Fiore LD; Lawler EV
Clin Infect Dis; 2012 Jan; 54(1):33-42. PubMed ID: 22100573
[TBL] [Abstract][Full Text] [Related]
5. Chronicity of Voice-Related Health Care Utilization in the General Medicine Community.
Cohen SM; Lee HJ; Roy N; Misono S
Otolaryngol Head Neck Surg; 2017 Apr; 156(4):693-701. PubMed ID: 28171737
[TBL] [Abstract][Full Text] [Related]
6. Otolaryngology utilization of speech-language pathology services for voice disorders.
Cohen SM; Dinan MA; Kim J; Roy N
Laryngoscope; 2016 Apr; 126(4):906-12. PubMed ID: 26308555
[TBL] [Abstract][Full Text] [Related]
7. Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia.
Jena AB; Sun E; Goldman DP
J Gen Intern Med; 2013 Feb; 28(2):223-30. PubMed ID: 22956446
[TBL] [Abstract][Full Text] [Related]
8. Prescribing patterns of primary care physicians and otolaryngologists in the management of laryngeal disorders.
Cohen SM; Kim J; Roy N; Courey M
Otolaryngol Head Neck Surg; 2013 Jul; 149(1):118-25. PubMed ID: 23585154
[TBL] [Abstract][Full Text] [Related]
9. Associations between Community-Acquired Pneumonia and Proton Pump Inhibitors in the Laryngeal/Voice-Disordered Population.
Sataloff RT
Otolaryngol Head Neck Surg; 2019 Sep; 161(3):545-546. PubMed ID: 31478472
[No Abstract] [Full Text] [Related]
10. Change in diagnosis and treatment following specialty voice evaluation: A national database analysis.
Cohen SM; Kim J; Roy N; Wilk A; Thomas S; Courey M
Laryngoscope; 2015 Jul; 125(7):1660-6. PubMed ID: 25676541
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitor therapy predisposes to community-acquired Streptococcus pneumoniae pneumonia.
de Jager CP; Wever PC; Gemen EF; van Oijen MG; van Gageldonk-Lafeber AB; Siersema PD; Kusters GC; Laheij RJ
Aliment Pharmacol Ther; 2012 Nov; 36(10):941-9. PubMed ID: 23034135
[TBL] [Abstract][Full Text] [Related]
12. Associations between Community-Acquired Pneumonia and Proton Pump Inhibitors in the Laryngeal/Voice-Disordered Population.
Cohen SM; Lee HJ; Leiman DA; Roy N; Misono S
Otolaryngol Head Neck Surg; 2019 Sep; 161(3):546-547. PubMed ID: 31478473
[No Abstract] [Full Text] [Related]
13. Diagnosis change in voice-disordered patients evaluated by primary care and/or otolaryngology: a longitudinal study.
Cohen SM; Dinan MA; Roy N; Kim J; Courey M
Otolaryngol Head Neck Surg; 2014 Jan; 150(1):95-102. PubMed ID: 24264568
[TBL] [Abstract][Full Text] [Related]
14. Proton Pump Inhibitors and the Risk of Community-Acquired Pneumonia: An Updated Meta-analysis.
Xun X; Yin Q; Fu Y; He X; Dong Z
Ann Pharmacother; 2022 May; 56(5):524-532. PubMed ID: 34425689
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing referral of patients with voice disorders from primary care to otolaryngology.
Cohen SM; Kim J; Roy N; Courey M
Laryngoscope; 2014 Jan; 124(1):214-20. PubMed ID: 23794289
[TBL] [Abstract][Full Text] [Related]
16. Proton-pump inhibitor use and the risk for community-acquired pneumonia.
Sarkar M; Hennessy S; Yang YX
Ann Intern Med; 2008 Sep; 149(6):391-8. PubMed ID: 18794558
[TBL] [Abstract][Full Text] [Related]
17. A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.
Hsiao FY; Tsai YW; Huang WF; Wen YW; Chen PF; Chang PY; Kuo KN
Clin Ther; 2009 Sep; 31(9):2038-47. PubMed ID: 19843493
[TBL] [Abstract][Full Text] [Related]
18. Voice disorders in the elderly: A national database study.
Roy N; Kim J; Courey M; Cohen SM
Laryngoscope; 2016 Feb; 126(2):421-8. PubMed ID: 26280350
[TBL] [Abstract][Full Text] [Related]
19. Proton Pump Inhibitors and Infant Pneumonia/Other Lower Respiratory Tract Infections: National Nested Case-control Study.
Blank ML; Parkin L; Zeng J; Barson D
J Pediatr Gastroenterol Nutr; 2018 Sep; 67(3):335-340. PubMed ID: 29601438
[TBL] [Abstract][Full Text] [Related]
20. Are proton pump inhibitors associated with the development of community-acquired pneumonia? A meta-analysis.
Giuliano C; Wilhelm SM; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2012 May; 5(3):337-44. PubMed ID: 22697595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
